CP 154526

Known as: CP 154,526, CP-154,526, CP-154526 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2018
051019962018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Kappa opioid agonists were at one time proposed as candidate pharmacotherapies for cocaine addiction, mainly because of their… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Systemic injections of the selective corticotropin-releasing factor 1 (CRF1) receptor antagonist CP-154,526 attenuate footshock… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Previous work demonstrated that rats subjected to multiple withdrawals from chronic ethanol exhibit a sensitization of anxiety… (More)
Is this relevant?
2004
2004
The brain corticotropin-releasing hormone (CRH) circuits are activated by stressful stimuli, contributing to behavioral and… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Rationale: Intermittent footshock stress reliably reinstates extinguished alcohol-taking behavior in drug-free rats, but the… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND & AIMS Corticotropin-releasing factor (CRF) exerts its action through CRF receptors 1 and 2 (CRF-R1 and CRF-R2). CRF… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Two different corticotropin-releasing factor (CRF) receptors, CRF1 and CRF2, have been identified in rat and human brain… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
We have found that peptide antagonists of corticotropin-releasing factor (CRF) receptors attenuate reinstatement of heroin and… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
1997
Highly Cited
1997
The effects of CP-154,526 (butyl-ethyl-[2,5-dimethyl-7-(2,4,6 -trimethyl-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-amine), a… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Here we describe the properties of CP-154,526, a potent and selective nonpeptide antagonist of corticotropin (ACTH) releasing… (More)
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?